Sotera Health Company (SHC)

Market Cap	4.43B +21.9%
Revenue (ttm)	1.19B +7.4%
Net Income	117.79M +374.7%
EPS	0.41 +366.8%
Shares Out	285.17M
PE Ratio	38.05
Forward PE	15.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,891,481
Open	15.50
Previous Close	15.64
Day's Range	15.37 - 15.78
52-Week Range	10.80 - 19.85
Beta	1.82
Analysts	Buy
Price Target	20.13 (+29.54%)
Earnings Date	May 5, 2026

About SHC

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion seg...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 20, 2020
• Employees: 3,000
• Stock Exchange: NASDAQ
• Ticker Symbol: SHC
• Website: https://soterahealth.com

Financial Performance

In 2025, Sotera Health Company's revenue was $1.16 billion, an increase of 5.74% compared to the previous year's $1.10 billion. Earnings were $77.95 million, an increase of 75.79%.

Analyst Summary

According to 10 analysts, the average rating for SHC stock is "Buy." The 12-month stock price target is $20.13, which is an increase of 29.54% from the latest price.

Price Target

$20.13

(29.54% upside)

Analyst Consensus: Buy